Zurich: Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The technology is potentially life-changing for many diabetics, who prick their fingers as many as 10 times daily to check their body's production of the sugar.
Success would allow Novartis to compete in a global blood-sugar tracking market that is expected to be worth over $12 billion by 2017, according to research firm GlobalData. Diabetes afflicts an estimated 382 million people worldwide.
The second approach is for presbyopia, in which aging eyes have trouble focusing on close objects. Novartis hopes the lens technology will help restore the eye's ability to focus, almost like the autofocus on a camera.
Non-invasive sensors, microchips and other miniaturised electronics would be embedded into the contact lenses.
Under the deal with Google, Novartis's Alcon eyecare unit will further develop and commercialise the lens technologies designed by Google[x], the American company's development team.
Financial details were not disclosed.
The alliance comes as drugmakers explore ways for technology to reshape healthcare, helping patients monitor their own health and lowering the costs of managing chronic diseases.
In turn, technology firms such as Apple Inc, Samsung Electronics Co and Google are trying to find health-related applications for wearable devices.
Novartis Chief Executive Joe Jimenez said he hoped a product could be on the market in about five years' time.
"This really brings high-technology and combines it with biology and that's a very exciting combination for us," Jimenez told Reuters.
"I think you're going to see more and more areas of unmet medical need where companies like Novartis are going to take a non-traditional approach to addressing those unmet needs."
Although the licensing deal is just for the eye, Jimenez said the drugmaker was also thinking about how technology could be applied in other areas, such as remote patient monitoring in heart failure.
The device for diabetics would measure glucose in tear fluid and send the data wirelessly to a mobile device, Novartis said. The technology is potentially life-changing for many diabetics, who prick their fingers as many as 10 times daily to check their body's production of the sugar.
Success would allow Novartis to compete in a global blood-sugar tracking market that is expected to be worth over $12 billion by 2017, according to research firm GlobalData. Diabetes afflicts an estimated 382 million people worldwide.
Non-invasive sensors, microchips and other miniaturised electronics would be embedded into the contact lenses.
Advertisement
Financial details were not disclosed.
Advertisement
In turn, technology firms such as Apple Inc, Samsung Electronics Co and Google are trying to find health-related applications for wearable devices.
Advertisement
"This really brings high-technology and combines it with biology and that's a very exciting combination for us," Jimenez told Reuters.
Advertisement
Although the licensing deal is just for the eye, Jimenez said the drugmaker was also thinking about how technology could be applied in other areas, such as remote patient monitoring in heart failure.
© Thomson Reuters 2014
COMMENTS
Advertisement
Google Maps Shows Walking 6 Km Is Faster Than Driving In Bengaluru. See Post Gemini 1.5 Flash AI Model Will Now Power Google’s AI Chatbot on Web and App Google CEO Sundar Pichai Gets Honorary Doctorate From IIT-Kharagpur: "My Parents Always...'' Student Dies, 2 Others Trapped In Delhi Coaching Centre's Flooded Basement At Olympics Opening Ceremony, Drag Parody Of 'The Last Supper' Draws Flak US Scientists Play God: New Element Created In A Lab Experiment DSSSB Exam Schedule 2024 Released For Recruitment To Various Posts AAP's Atishi Calls For Meeting After Delhiites Complain Of Blue Tap Water Woman Gym Trainer, 21, Killed Inside Delhi Flat Track Latest News Live on NDTV.com and get news updates from India and around the world.